Royalty Report: Genome, Drugs, Agriculture – Collection: 266848

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 10

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 10

Primary Industries

  • Genome
  • Drugs
  • Agriculture
  • Forestry and Fishing
  • Software
  • ribonucleic acid
  • Proteins
  • Content
  • Cancer
  • Disease
  • Drug Discovery
  • Molecular
  • Enzymes

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 266848

License Grant
For the License of Platform Technology and Biomolecules, Licensor grants the Swiss Licensee a perpetual, exclusive, worldwide license, with the right to sublicense, under the Patent Rights and Know-How Controlled by Licensor and its Affiliates to make, have made and use all of the Biomolecules that demonstrated the minimum criteria levels specified in the applicable Project Plans to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Licensee Exclusive Field.

Licensor agrees to grant to Licensee and its Affiliates a perpetual, worldwide license, with the right to sublicense, under the Patent Rights and Know-How Controlled by Licensor and its Affiliates to make, have made and use all other Biomolecules discovered or provided in the course of the Projects under the Research Program which did not demonstrate such minimum criteria levels to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Licensee Exclusive Field provided Licensor shall grant a license to such Biomolecule in the Licensee Exclusive Field to the greatest extent that Licensor has not granted such rights to a Third Party(ies).

Licensor agrees to grant a worldwide license, with the right to sublicense, to use the Platform Technology Improvements which are owned by Licensor in the Licensee Exclusive Field.

License Property
The licensed patents include, but are not limited to, Method For Identification, Separation And Quantitative Measurement Of Nucleic Acid Fragments;  System And Method For High Throughput Tissue Disruption;  System And Method For Storing Mass Spectrometry Data; and,  identification of Protein Interactions Using In Vitro Post-Translationally Modified Fusion Proteins.

Platform Technology means all tools, technologies and methods relating to proteomics, metabolomics, RNA dynamics and bioinformatics and methods to analyze and link these components of genomics, which are both not publicly available and are proprietary to or Controlled by Licensee or its Affiliates immediately prior to the closing of the transactions under the Transaction Agreement, and claimed or disclosed within the patent applications and patents or are within the scope of the material trade secrets related thereto.

Biomolecule means any Gene and RNA and protein or chemical entity the synthesis of which is directed by such Gene or Gene pathway, which protein or chemical entity was produced by an organism.

Gene means a polynucleotide sequence which can be transcribed into RNA and generally encodes a protein, optionally together with its regulatory sequences.

Plant means a monocotyledonous or dicotyledonous plant, or an angiosperm, a gymnosperm or a pteridophyte.

Field of Use
Licensee Exclusive Field means  any Biomolecule with Plants as the expression host;  any Plant Gene; any Biomolecule for admixture to the product of any physical or chemical processing of Crops or derivatives of Crops provided that the product contains Plant material unique to Plants; any Biomolecule for any industrial application involving Crops or the close derivatives of Crops, but excluding inert or minor ingredients from or derived from a Plant source which do not materially add value to an end product of an industrial manufacturing process; any Biomolecule useful for Licensees actual or potential customers in the agriculture, food and/or natural fibers markets involving the use of Crops, or the use of close derivatives of Crops (including all uses of corn, wheat, barley, rice, cotton and soy, and other oil Crops and their close derivatives), but excluding inert or minor ingredients from or derived from a Plant source which do not materially add value to an end product of an industrial manufacturing process; any Biomolecule with commercial value, alone or In combination with other Biomolecules, for use in the Animal Feed Field; and, any Project described in the Project List and including the new protein therapeutic projects undertaken.

Animal Feed Field means the use of Biomolecules for feed applications to alter, modify or improve feed conversion and/or animal nutrition, but excluding all vaccines and therapeutic applications and any part of such field to which rights have been granted to Licensee or Licensee or any of its Affiliates under the Licensee Agreements.

IPSCIO Record ID: 203290

License Grant
This License of Biomolecules and TMRI Platform Technology Improvements grants various rights depending on biomolecules, exclusivity and the fields of use.

For Exclusive Biomolecule License, Licensor grants to the Swiss Licensee and its Affiliates an exclusive, worldwide license, with the right to sublicense, under the Patent Rights and Know-How Controlled by Licensor and its Affiliates
– (A) to make, have made, and use all of the Existing Biomolecules that demonstrated the minimum criteria levels specified in the applicable Project Plans under the Research Collaboration Agreement prior to the Effective Date and that are produced using any means of production to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Former Licensee Exclusive Field, the Licensee Exclusive Field, the Biofuel Field, and/or Other Existing Research;
– (B) to make, have made, and use all of the Existing Biomolecules that have not demonstrated the minimum criteria levels specified in the applicable Project Plans under the Research Collaboration Agreement prior to the Effective Date and that are produced using Transgenic Expression to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Licensee Exclusive Field;
– (C) to make, have made, and use those specific Existing Biomolecules listed that have not demonstrated the minimum criteria levels specified in the applicable Project Plans under the Research Collaboration Agreement prior to the Effective Date and that are produced using any means of production including Fermentation and Transgenic Expression to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Animal Feed Field;
– (D) to make, have made, and use those specific Existing Biomolecules listed that have not demonstrated the minimum criteria levels specified in the applicable Project Plans under the Research Collaboration Agreement prior to the Effective Date and that are produced using any means of production including Fermentation and Transgenic Expression to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Biofuel Field and/or the Animal Feed Field;
– (E) to make, have made, and use all of the Biomolecules discovered or identified under the Research Program that are produced using Transgenic Expression to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Licensee Exclusive Field and/or the Other Existing Research;
– (F) to make, have made, and use all of the Subsequent Biomolecules referenced that are produced using Transgenic Expression to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Licensee Exclusive Field; and
– (H) to use for any purpose fermentable sugars, other chemicals and/or byproducts resulting from conversion of Biomass (such as lignins) in each case that result from exercise of the rights under any of the foregoing licenses.

For Non-Exclusive Biomolecule License, Licensor grants to the Swiss Licensee and its Affiliates a non-exclusive license, with the right to sublicense, under the Patent Rights and Know-How Controlled by Licensor and its Affiliates
– (A) to make, have made and use any Biomolecules discovered or identified under the Research Program that demonstrate the minimum criteria levels specified in the applicable Project Plans on or after the Effective Date and that are produced by Fermentation and included as a component in a Mixed Delivery Product to use, develop, make, have made, import, sell, offer for sale and have sold such Mixed Delivery Product for use in the Animal Feed Field and/or Biofuel Field;
– (B) to make, have made and use all of the Subsequent Biomolecules referenced that are produced by Fermentation and included as a component in a Mixed Delivery Product to use, develop, make, have made, import, sell, offer for sale and have sold Licensee Products for use in the Animal Feed Field and/or Biofuel Field; and
– (C) to use for any purpose fermentable sugars, other intermediate chemicals and/or byproducts resulting from conversion of Biomass (such as lignins) in each case that result from exercise of the rights under any of the foregoing licenses.

For the License of TMRI Platform Technology Improvements, Licensor grants the Swiss Licensee and its Affiliates an irrevocable, worldwide license, with the right to sublicense, to use the TMRI Platform Technology Improvements which are owned or otherwise Controlled by Licensor, in the Licensee Exclusive Field and in the Former Licensee Exclusive Field, it being understood and agreed that such license shall be exclusive during the Research Term and thereafter, such license shall be non-exclusive.

License Property
TMRI Platform Technology means all tools, technologies and methods relating to proteomics, metabolomics, RNA dynamics and bioinformatics and methods to analyze and link these components of genomics.

“Biomolecule” means any Gene, RNA, and protein or chemical entity the synthesis of which is directed by such Gene or Gene pathway, which protein or chemical entity was produced by an organism.

“Fermentation” means a microbial fermentation process, including, without limitation, bacterial-, fungal- and yeast-based fermentation.

Field of Use
Animal Feed Field” means the use of Biomolecules in feed applications to alter, modify or improve feed conversion and/or animal nutrition, which Biomolecules may be produced or expressed through any means including without limitation through Fermentation or Transgenic Expression, but excluding all vaccines and therapeutic applications.

Biofuel Field” means the hydrolytic conversion of Biomass to fermentable sugars and/or other chemicals for use in fuel production. For the avoidance of doubt, the “Biofuel Field” shall not include the pre-treatment of Biomass to make it suitable for hydrolysis or the development and use of organisms designed to ferment the products of hydrolysis to fuels and/or other chemicals.

“Biomass” means material that originates from Plants which can be or is intended to be used as a feedstock in the research, development and/or production of biofuels and bioproducts, including without limitation bioethanol, biodiesel, other fuels for energy applications and chemicals for any purpose, including without limitation agricultural, food and non-food crops and their residues and wastes (e.g. normally non-food material from crops such as stalks, leaves, husks, seed fiber, hulls), forestry residues and wastes (e.g. wood chips, sawdust, cardboard, pressboard, dead trees, tree branches), municipal solid waste (e.g. household garbage and paper products), food processing and other industrial wastes, energy crops (e.g. fast growing trees and grasses grown for this purpose), including, but not limited to, corn stover, switchgrass, and sugar cane bagasse, as well as trees; Biomass is often significantly composed of cellulose, hemi cellulose and lignin structures and may also include oil crops and starch components of crops.

IPSCIO Record ID: 230814

License Grant
The original research collaboration agreement was entered to discover and develop new Biomolecules and Products based on such Biomolecules utilizing the technology licensed by the Swiss Licensee to Licensor as well as Licensors technology and expertise.

This agreement is to provide for, among other things, the transfer of certain projects undertaken under the Licensees Affiliates Agreement and the Joint Venture Agreement to the Research Collaboration Agreement, as amended by this Amendment.

The Parties desire to amend the Research Collaboration Agreement in accordance with the Transition Agreement to provide for, among other things, the transfer of certain projects undertaken under the Affiliates Agreement and the Joint Venture Agreement to the Research Collaboration Agreement, as amended by this Amendment.

With this amendment, Licensor grants the Swiss Licensee the exclusive option to include the Affiliates Animal Feed Field in the Licensees Exclusive Field under the terms of the Research Collaboration Agreement, as amended.

Licensor grants an exclusive option to develop and commercialize the product known as D45 and all derivatives thereof on a sole and exclusive basis in the Licensees Exclusive Field.

License Property
Animal Feed Field means the use of Biomolecules for feed applications to alter, modify or improve feed conversion and/or animal nutrition, but excluding all vaccines and therapeutic applications.

Approved Affiliates Research Projects means the projects in existence under the Affiliates Agreement known as Coarse Grain Glucanase, Coarse Grain Amalase and Coarse Grain Protease.

All Biomolecules developed or invented under the Affiliates Agreement and Joint Venture Agreement shall be made available for research, development and commercialization and shall be treated as Biomolecules in all respects, under the Research Collaboration Agreement, as amended by this Amendment, including, without limitation
(a) the Pre-Amendment Inventions;
(b) the Post-Amendment Inventions;
(c) all of such Biomolecules tested under the criteria set forth in the project plans to establish TB or COB status under the Affiliates Agreement as of the Effective Date but that did not meet the applicable Minimum Activity Level ( as such term is defined in the Affiliates Agreement); and·
(d) all of such Biomolecules for which specific gene sequence data is not available as of the date of execution of this Amendment but whose activity was detected in the applicable screen set forth in the applicable project plan under the Affiliates Agreement.

Field of Use
Licensors Field of Exploitation means products based on microbially-derived Biomolecules, not produced in Plants, for use in the pulp and paper industry solely for deinking, pitch control, papermachine boilout cleaning, deposit control, fiber strengthening, and reduction of bleaching chemicals.

IPSCIO Record ID: 294285

License Grant
For the Exclusive Licenses, Licensor grants an exclusive license including the right to sublicense, under the Licensor Patent Rights and Licensor Technology to develop, make, have made, use, sell, offer for sale and import Biomolecules and Licensed Products in the Territory.

For the Non-Exclusive Research Licenses, Licensor grants a non-exclusive, irrevocable, perpetual license in the Territory, to use solely for research done by Licensee or its Affiliates or by Third Party contractors for Licensee or its Affiliates the Licensor Technology, excluding any Licensor Technology that is now or hereafter during the Term covered by claims in issued patents or published patent applications disclosed to Licensee during the Term.

License Property
Licensor owns or controls certain patents, patent applications, technology,know-how and scientific and technical information relating to Biomolecules and Licensed Products.

Applicable Biomolecule means a Biomolecule as to which Licensor at any time during the Term commenced IND-enabling toxicity studies or clinical trials.

Product means any product, including any pharmaceutical product or diagnostic product, which contains any Biomolecule, either alone or in combination with any other active pharmaceutical ingredient, in all formulations and strengths for all uses.

Combination Product means any pharmaceutical product containing a Biomolecule and one or more other active phannaceutical ingredients.

Field of Use
License relates to Licensor’s human gene RTP-801 and to molecules that modify its expression or function under a new agreement between the two companies. RTP-801 is involved in the development of pathologic blood vessels that accelerate the progression of age-related macular degeneration (AMD).   Based on preclinical models, it is believed that AMD can be treated by blocking the expression of the RTP-801 gene through RNA interference or RNAi.

Licensee has extensive experience and expertise in the development and commercialization of pharmaceutical products.  Licensor is a clinical-stage pharmaceutical company engaged in discovering and developing novel RNAi interference or RNAi-based therapeutics.

IPSCIO Record ID: 210378

License Grant
Licensor grants to Licensee under the Licensed Patent Rights except for those patent rights directed to DNA other than Arabidopsis DNA and, if the Project Plan is extended, except for those patent rights directed to DNA other than Arabidopsis and rice DNA, and for the life of such Licensed Patent Rights a perpetual non-exclusive world-wide license to make and use Project Technology and Licensor DNA Information directed to Arabidopsis DNA and, if the Project Plan is extended, rice DNA and a perpetual exclusive world- wide license to develop, make, have made, import, use, sell, have sold, and offer to sell Paradigm Licensed Products. Monsanto further grants Paradigm the right to sublicense the rights to develop, make, have made, import, use, sell, have sold, and offer to sell Paradigm Licensed Products.

For the research license Licensor grants Licensors interest in Licensed Patent Rights except for those patent rights directed to DNA other than Arabidopsis DNA and, if the Project Plan is extended, except for those patent rights directed to DNA other than Arabidopsis and rice DNA, and project technology a perpetual nonexclusive, world-wide license to use project Technology and Licensor DNA Information directed to Arabidopsis DNA and, if the Project Plan is extended, rice DNA for research purposes only.  Such right shall not extend to any other Licensor owned or in-licensed technology including Licensor DNA Information that is not from  Arabidopsis or, if the Project Plan is extended, rice.

For research license for Licensors Enabling Technology in research crops Licensor grants Licensors interest in Licensor Enabling Technology a perpetual, nonexclusive, U.S. and Europe only, license to use Licensor Enabling Technology in Arabidopsis, tobacco and, if the Project Plan is extended, rice for research purposes only.

License Property
Licensor has certain rights relating to genes which impart traits in plants and plants containing such genes, such rights including possession of technical information and know-how relating to such plants and their use.

The Licensed Product means a particular product or a particular species of animals, plants, plant or animal parts, animal progeny, seed of plants and products from any of the foregoing, or the process of making any of the above.

Field of Use
This agreement is for the industry of gene sequences.  Licensee has expertise in transforming Arabidopsis plants with DNA and analyzing the resultant plants for functional changes.

IPSCIO Record ID: 233483

License Grant
This restated, amended agreement is to provide for the expansion of the collaborative efforts of the parties.

For the Research Database License,  Licensor grants an exclusive, worldwide license to use the Research Databases solely for its internal research purposes to identify Gene Targets during the Research Term.

For the Gene Target License
(a) Licensor grants and agrees to grant a non-exclusive, worldwide license, without the right to sublicense, under the Patent Rights and Gene Target Know-How Controlled by Licensor, if any, to use such Gene Target in the Field of Use.
(b) If Licensee has requested rights to such Gene Target in an Additional Field of Use and provided that Licensor has not previously granted an exclusive license or right to such Gene Target to a Third Party in such Additional Field of Use, Licensor grants and agrees to grant an exclusive, worldwide license, with the right to sublicense, under the Patent Rights and Gene Target Know-How Controlled by Licensor, if any, to develop, make, have made, use, import, offer for sale and sell such Gene Target in such Additional Product Field of Use.

For Ownership of Improvements to Licensee Technology, Licensor grants an exclusive, irrevocable, perpetual, worldwide license, with right to sublicense through multiple tiers of sublicense, to such rights.

License Property
Licensor has developed technologies and know~how with respect to high throughput analysis of gene expression and gene regulation for use in the identification of drug targets and the discovery of pharmaceutical and diagnostic products.

Research Databases shall mean the databases created by Licensor using the Licensor Technology pursuant to the Research Plans and containing all of the data derived from experiments conducted with respect to Samples.

Research Programs shall mean the programs of research performed by the parties for the research, discovery and characterization of genes through the application of genomic technologies and bioinformatics to analyze Samples, and the use of such genes for the development and commercialization of Products. The term genomic technologies shall mean, without limitation, technologies for the analysis of gene expression and gene regulation, hybridization array techniques, high speed sequencing and generation of expressed sequence tags.

Product shall mean a Therapeutic Product, Protein Product, Diagnostic Product or Nucleic Acid Product, as applicable.

Gene Products shall mean all partial cDNAs, DNAs, genes, full length cDNAs corresponding thereto and proteins encoded therefrom.

Field of Use
Field of Use shall mean all internal research uses by Licensee of Gene Targets and the development and commercialization of those Therapeutic Products. All uses of Gene Targets as Protein Products, Therapeutic Products, Nucleic Acid Products or Diagnostic Products are excluded from the Field of Use.

Additional Field of Use shall mean all uses of Gene Targets for the development and commercialization of Gene Targets as Protein Products or those Therapeutic Products, Nucleic Add Products and/or Diagnostic Products, as applicable.

Excluded indications are Intrinsic kidney disease, including but not limited to glomerulonepbritis and diabetic nephropathy;  Benign prostatic hypertrophy {specifically excluding prostate cancer); and, Atherosclerosis.

Licensor has been using its Reads gene expression technology to build a database of genes differentially expressed between normal heart tissue and heart tissue from people with heart failure. Under the expansion, the Licensor will enlarge the Licensee database to include new indications, beginning with osteoporosis.

IPSCIO Record ID: 209541

License Grant
Licensor agrees to assign right, title and interest to the Gene Patent Rights.

Licensor grants interest in the Licensed Patent Rights and for the life of such Licensed Patent Rights a perpetual non-exclusive, world-wide license to make and use Project Technology and Licensee DNA Information and a perpetual exclusive, world-wide license to develop, make, have made, import, use, sell, have sold, and offer to sell Licensee Licensed Products. Licensor further grants the right to sublicense any of the above rights.

For Licensor Gene Patent Rights, Licensor grants interest in Licensor Gene Patent Rights a perpetual non-exclusive, world-wide license to use Licensee DNA Information for research purposes only. Such right shall not extend to any other Licensor owned or in-licensed technology.

License Property
Licensor has expertise in transforming Arabidopsis plants with DNA and analyzing the resultant plants for functional changes, including possession of technical information and know how relating to such plants and their analysis and use, and ownership of U.S. and foreign patent applications covering the plants, genes and their use.

The Licensed Product means a particular product or a particular species of animals, plants, plant or animal parts, animal progeny, seed of plants and products from any of the foregoing, or the process of making any of the above.  Licensor has expertise in transforming Arabidopsis plants with DNA and analyzing the resultant plants for functional changes.

Field of Use
This agreement is for the industry of gene sequences.  Licensee has certain rights relating to genes which impart traits in plants and plants containing such genes, such rights including possession of technical information and know-how relating to such plants and their use.

IPSCIO Record ID: 282872

License Grant
Licensor grants a world-wide, exclusive license under the Licensor Technology to make, have made, use, sell, offer for sale, and import Licensed Products and to provide Licensed Services, but excluding all uses of Licensed Products or Licensor Technology in the Plant Field and excluding all Plant Products, in each case solely in the Field and a world-wide, co-exclusive license under the Licensor Technology to make, have made, use, sell, offer for sale, and import Permitted Plant Products and to provide Permitted Plant Services, in each case solely in the Field.
License Property
Linensor has proprietary technology relating to, zmc finger proteins and their use to alter the genomes and/or protein expression capabilities of organisms and cells.

Active Supplied ZFN shall mean a Supplied ZFN having demonstrated ability to modify at least one allele of the applicable Target in a cell culture assay or other in vivo assay.

Licensed Product means any product the creation, development, manufacture, use, importation, sale or offer for sale of which, in the absence of the licenses granted in this Agreement, would infringe a Valid Claim or that incorporates Licensor Know-How, or any Licensed Service.

Supplied ZFN means nucleic acids encoding a single pair of zinc-finger protein nucleases directed against a Target.

ZFN Technology means technology relating to zinc finger proteins and their use to alter the genomes and/or protein expression capabilities of organisms and cells.

ZFP Product means a zinc-finger protein (including a zinc-finger transcription factor or a zinc-finger nuclease) or a nucleic acid encoding and capable of expressing such protein (for example, in a cell or tissue), and services in connection therewith.

Field of Use
Field means any use for research purposes. The Field shall exclude any Commercial Use of Licensed Products and any use of Licensed Products for human healthcare, including prophylaxis and diagnosis or animal healthcare including prophylaxis and diagnosis, collectively, the Excluded Fields.  

Plant Field means gene targeting and/or gene regulation using a ZFP Product to modify the genome of a plant cell, plant, or plant cell culture (in each case, whether constituting or derived from a vascular or non-vascular plant), or alter the nucleic acid or protein expression in a plant cell, plant, or plant cell culture. For the purpose of this Agreement, nonvascular plants shall include but not be limited to algae, moss, and fungi.

IPSCIO Record ID: 289149

License Grant
With respect to each Development Biomolecule, Licensor grants an exclusive option to receive an exclusive, worldwide license so long as Licensor has not previously granted rights to such Development Biomolecule to a third party; provided that, at Licensees sole election, such License shall be non-exclusive rather than exclusive, in which case the Parties agree that the License Fee and royalty rate shall be determined by mutual agreement of the Parties taking into account a non-exclusive License.

For Licenses In the event that Licensee exercises the Option prior to the end of the Option Period, Licensor will grant a License under the Licensor Technology to use the applicable Licensed Biomolecule to the extent necessary to make, have made, use, sell, offer for sale and import Royalty-Bearing Products in the applicable Licensee Field.

License Property
Licensor has isolated and characterized a group of enzymes known as esterases.

For the Scope of License, the Parties hereby agree that the Novartis Field related to the Initial Projects is for the Biopanning Project, Molecular Evolution Project, Lead Identification Project and Barley Project.

Field of Use
Use shall mean each use or application for which any Licensed Biomolecule is being developed,or any Royalty-Bearing Product is being commercialized. In the event of  transnsgenic applications each crop will represent a different use.

The enzymes will be used for screening against a number of insect targets.

The initial projects focus on new genomic approaches that will provide improved performance and quality traits in crops and enhance production.

IPSCIO Record ID: 204996

License Grant
For Research use, Licensor grants a non-exclusive, nontransferable, nonsublicensable, worldwide license under Licensor s interest in the Intellectual Property and Materials, and a non-exclusive, nontransferable, non-sublicensable, worldwide license under any patents, trade secrets and other intellectual property owned or Controlled by Licensor that are necessary or useful for the conduct of the R&D Program.

For Commercial use, Licensor agrees to grant, and hereby grants, a worldwide, royalty-bearing license under Licensors interest in the Intellectual Property, as follows
– an exclusive license to make, have made, and use Shuffled Genes, excluding any Licensor SGD, and Enabling Technology together with Shuffled Genes, excluding any Licensor SGD, in each case, in Licensees Crops, to develop, make, have made, propagate, have propagated, use, import, offer for sale, sell and have sold Licensee Licensed Products, including the right to grant sublicenses ; and
– a non-exclusive license to make, have made, and use Research Results subject to and in Licensee Crops, to develop, make, have made, use, import, offer for sale, sell and have sold Licensee Licensed Products, including the right to grant sublicenses.

Licensor grants, a worldwide, license under Licensors interest in the Intellectual Property as follows
– an exclusive license to make, have made, sell, offer to sell, import and use Shuffled Genes, excluding Licensor SGDs, in Plants other than Licensor Crops and Licensee Crops, and for uses other than in Plants, and to develop, make, have made, use, import, offer for sale, sell and have sold Licensee Licensed Products derived therefrom, including the right to grant sublicenses; and
– a non-exclusive license to make, have made, sell, offer to sell, import and use Research Results subject to and in Plants other than Licensor Crops and Licensee Crops, and for uses other than in Plants, and to develop, make, have made, use, import, offer for sale, sell and have sold Licensee Licensed Products derived therefrom, including the right to grant sublicenses.

License Property
Licensor has expertise in the breeding and development of proprietary crop species.
Field of Use
Licensee has expertise in the rearrangement of DNA to produce and discover genes utilizing proprietary technologies.  This agreement is to produce improved seeds and agricultural products,
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.